Podcast by NIA IMPACT Collaboratory
Podcast 48: Current and future use of RE-AIM and its PRISM expansion by NIA IMPACT Collaboratory
Podcast 47: The GUIDE Model by NIA IMPACT Collaboratory
Podcast 46: The WHELD Programme by NIA IMPACT Collaboratory
Podcast 45: Diagnosed Dementia in Medicare - Benchmarking for Study Planning and Equity by NIA IMPACT Collaboratory
Podcast 44: Cultural Adaptation of ADRD Clinical Trials for Latino Participants by NIA IMPACT Collaboratory
Podcast 43: Strategies to Implement ePCTs in Home and Community-Based Settings by NIA IMPACT Collaboratory
Podcast 42: The Clinical Implementation of Alzheimer's Disease Biomarkers by NIA IMPACT Collaboratory
Podcast 41: Outcomes Truncated by Death in Randomized Trials by NIA IMPACT Collaboratory
Podcast 40: Electronic Nudges and Pragmatic Trials to Improve Hospital Palliative Care Delivery by NIA IMPACT Collaboratory
Podcast 38: Results and Lessons Learned from the HAS-QOL ePCT by NIA IMPACT Collaboratory
Podcast 37: eRADAR: Using electronic health record data for targeted dementia screening by NIA IMPACT Collaboratory
Podcast 36: More than a Meal: Results from a Pilot Pragmatic Trial on Home-Delivered Meals by NIA IMPACT Collaboratory
Podcast 35: Causal Inference in Pragmatic Trials by NIA IMPACT Collaboratory
Podcast 34: Methods for designing cluster randomized trials to detect treatment effect heterogeneity by NIA IMPACT Collaboratory
Podcast 33: Adaptation of behavioral interventions and use of FRAME by NIA IMPACT Collaboratory
Podcast 32: The REGAIN Trial Experience by NIA IMPACT Collaboratory
Podcast 31: Vulnerability in cluster randomized trials involving people living with dementia by NIA IMPACT Collaboratory
Podcast 30: Developing standards and quality metrics for clinical phenotypic using EHR data by NIA IMPACT Collaboratory
Podcast 29: CHATO design, pilot testing and update on current implementation and results by NIA IMPACT Collaboratory
This podcast follows up on Grand Rounds 22 and includes additional insights from a panel of participants sharing their experiences in stakeholder engagement in ePCTs for people living with AD/ADRD and their care partners. Perspectives shared include that of researcher, stakeholder engagement expert and people living with dementia.
Jennifer Gabbard, MD, and Ariel Green, MD, MPH, PhD, share research updates and experiences on IMPACT Cycle 2A Pilot Studies.
Podcast 27: Deprescribing Education v. Usual Care: The OPTIMIZE Pragmatic Cluster Randomized Trial by NIA IMPACT Collaboratory
Podcast 24: Lessons From the First Decade of the NIH Pragmatic Trials Collaboratory by NIA IMPACT Collaboratory
Podcast 23: Healthcare-Generated Data to Identify PLWD for Embedded Pragmatic Trials by NIA IMPACT Collaboratory
Podcast 21: Challenges in interventions for care partner of people living with dementia by NIA IMPACT Collaboratory
Grand Rounds 20: Dyadic designs, their foundation on theory and analytic methods by NIA IMPACT Collaboratory
Podcast 19: Challenges Implementing Innovative Programs in Long Term Care by NIA IMPACT Collaboratory
Podcast 18: Promises and Pitfalls of Existing Data in Nursing Homes by NIA IMPACT Collaboratory
Podcast 17: Pilot and feasibility studies for pragmatic cluster randomised trials by NIA IMPACT Collaboratory
This podcast continues the conversation with Consuelo Wilkins, MD, MSCI, on how to improve inclusion, diversity, and equity in pragmatic clinical trials. Susan L. Mitchell, MD, MPH, moderated the discussion as they answer questions from Dr. Wilkins' Grand Rounds and expand on these very important ideas shared during the talk.
IMPACT members Brent P. Forester, MD, MSc and Ula Hwang, MD, MPH continue the conversation from their March 18 Grand Rounds webinar presentation on giving updates on two IMPACT funded pilot studies. The IMPACT Collaboratory funds several one-year pilot studies annually; these are meant to generate the preliminary data necessary to design and conduct a future full-scale Stage IV effectiveness ePCT (based on the NIH Stage Model) funded through other grant mechanisms (National Institutes of Health or other sources).
Stuart Nicholls, PhD, from the Clinical Epidemiology Program at the Ottawa Hospital Research Institute ,continues the discussion from his February 18 Grand Rounds presentation. This discussion with IMPACT Principal Investigator Susan Mitchell, MD, MPH answers questions from Dr. Nicholls's presentation on giving an overview of ethical issues raised by pragmatic randomized controlled trials (RCTs) and which derive from ongoing work to develop guidance for those designing and conducting pragmatic RCTs.
Ab Brody, PhD, RN, FAAN, Ellen McCreedy, PhD, MPH and Jessica Colburn, MD continue their conversation from their January 13 Grand Rounds webinar presentation. This discussion with IMPACT Principal Investigator Susan Mitchell, MD, MPH answers questions from their presentation on providing real world examples of implementation in ongoing AD/ADRD ePCTs in different health care settings.
Scott D. Halpern, MD, PhD, John M. Eisenberg Professor of Medicine, Epidemiology and Medical Ethics & Health Policy at the University of Pennsylvania Perelman School of Medicine continues the conversation from his December 17 Grand Rounds webinar presentation. This discussion with IMPACT Principal Investigator Vince Mor, PhD, covers questions from Dr. Halpern's presentation on improving serious illness care through large pragmatic trials.
Enola K. Proctor, PhD, Shanti K. Khinduka Distinguished Professor at Washington University's Brown School of Social work continues the topics discussed during her Grand Rounds presentation on implementation outcomes and their role in treatment success with IMPACT Executive Director Ellen McCarthy, PhD.
Eric B. Larson, MD, MPH and Joseph E. Gaugler, PhD continue the topics discussed during their Grand Rounds on the AHRQ and Lancet Reports on dementia interventions, interpretation and implications for embedded pragmatic trials with IMPACT Executive Director Jill Harrison, PhD.
IMPACT Collaboratory Podcast 9: Data-related Challenges for Pragmatic Trials Involving PLWD by NIA IMPACT Collaboratory
Eric Larson, Leah Hanson, David Reuben, and Jeff Williamson of the IMPACT Health Care Systems Core dive deeper into their discussion on how embedded pragmatic trials can benefit both health care systems and the research community. IMPACT PI Vince Mor moderates.
Executive Director for the IMPACT Collaboratory Jill Harrison speaks with Laura C. Hanson, MD, MPH and Sheryl Zimmerman, PhD about their recent IMPACT Collaboratory Grand Rounds. The Grand Rounds focused on finding pragmatic and relevant outcomes for AD/ADRD ePCTs.
Continuing the Conversation on COVID-19 among older persons in health care systems by NIA IMPACT Collaboratory
A conversation with the Cycle 1 IMPACT pilot study awardees by NIA IMPACT Collaboratory
IMPACT Collaboratory Podcast 6: Continuing the Conversation on Stakeholder Engagement by NIA IMPACT Collaboratory
Executive Director for the IMPACT Collaboratory Jill Harrison speaks with David C. Grabowski, PhD, Susan Mitchell, MD, MPH, and Vince Mor, PhD about their recent IMPACT Collaboratory Grand Rounds presentation on COVID-19 in Nursing Homes.
IMPACT Collaboratory PI Susan Mitchell speaks with Ana Quiñones, PhD, MS and Jonathan Jackson, PhD about their recent IMPACT Collaboratory Grand Rounds presentation on Health equity as foundational to the design of pragmatic trials.
IMPACT Collaboratory PI Vince Mor speaks with Jason Karlawish, MD about his recent IMPACT Collaboratory Grand Rounds presentation on Modifications and Waivers of Informed Consent in Pragmatic Clinical Trials. Karlawish, Professor of Medicine, Medical Ethics and Health Policy, and Neurology, and Co-Director of the Penn Memory Center at University of Pennsylvania, focuses his research on issues at the intersections of bioethics, aging and the neurosciences.
IMPACT Collaboratory PI Susan Mitchell and Ellen McCreedy, MD, MPH, discuss Dr. McCreedy's recent IMPACT Collaboratory Grand Rounds “Using a Pilot to Test and Refine Your Measurement Strategy.” McCreedy, an Assistant Professor at the Center for Gerontology and Healthcare Research at Brown University, focuses her research efforts on improving the quality of remaining life for people living with dementia.
IMPACT Collaboratory PI Vince Mor sits down with Monica Taljaard, PhD to dive deeper into her recent IMPACT Collaboratory Grand Rounds presentation of stepped wedge cluster randomized trials. Taljaard, Senior Scientist at Ottawa Hospital Research Institute, is a biostatistician specializing in the design, analysis and ethics of pragmatic cluster randomized and stepped wedge trial.
Podcast 1: Continuing the conversation about the RAPT Model by NIA IMPACT Collaboratory
© 2020-2025 Ivy Podcast Discovery LLC
